1.Hunan, Jiangxi, Guangdong, Hong Kong na Macao na-enyocha ụzọ ọhụrụ maka mmepe dị elu nke nkà mmụta ọgwụ ndị China.
Na 18th, emume mkpughe nke Hunan Jiangxi Guangdong Hong Kong Macao TCM dum Industry Chain Collaborative Development Alliance (nke a na-akpọ "Alliance") na Mahadum Hunan nke Omenala Ọgwụ Chinese.
Na November 16 nke afọ a, na nkwado nke CPPCC National Committee, State Administration of Traditional Chinese Medicine, na CPPCC Hunan, Jiangxi na Guangdong Provinces na mkpa ngalaba na Hong Kong na Macao, Alliance e ukara.
N'ememe mkpughe ahụ, Liu Liang, onye isi oche nke Alliance na onye mmụta nke CAE Member, yana ndị isi nke Hong Kong, Macao, Taiwan, Kọmitii na-ahụ maka ndị China na mba ofesi nke CPPCC Hunan Provincial Committee, Provincial. Nlekọta nke ọgwụ ndị China ọdịnala, Mahadum Hunan nke ọgwụ ọdịnala ndị China na ngalaba ndị ọzọ, wepụrụ ihe ncheta maka ụlọ ọrụ Alliance, ma nyekwa ya ihe ncheta maka Centerlọ Ọrụ Mmekọrịta Ọgwụ na China, Sayensị Sayensị na Teknụzụ Innovation Innovation Center, Centerlọ Ọrụ Mmekọrịta Ọgwụ na China. , na Ụlọ Ọrụ Mmekọrịta Ọgwụ na Azụmahịa China.
Ntọala nke ebe anọ ahụ bụ nzọụkwụ mbụ n'ịwube usoro mmepụta ihe niile nke "sayensị, ọrụ ugbo, ụlọ ọrụ, ahia na nkà mmụta ọgwụ" nke Alliance kwalitere, yana ọrụ dị ukwuu.Ebe anọ a ga-eji sayensị na teknụzụ mebie ọgwụ ndị China ọdịnala, nyochaa teknụzụ bụ isi nke ọgwụ ndị China ọdịnala, gbasaa elu, gbasa n'okpuru mmiri, mepụta aka mechiri emechi, melite ogo na arụmọrụ, nye egwuregwu zuru oke na ikike kachasị. elu na downstream njikọ nke atọ ógbè na abụọ mpaghara, n'ezie na-aghọta yinye njikọ, yinye supplementing na yinye ike, na hụ a qualitative itule na achikota mmepe nke mpaghara ulo oru yinye.
2.Welie ọnụahịa nke ihe ndị metụtara ọrịa na-efe efe, na-abawanye elu karịa 600%!Nnyocha siri ike!
N'ihi mgbanwe ọnụahịa na-adịghị mma na nso nso a n'ahịa ihe gbasara ọrịa na-efe efe, Ụlọ Ọrụ Na-ahụ Maka Ahịa nke Zhejiang mere ka nlekọta na mmanye nke ọnụ ahịa ọgwụ na-efe efe metụtara ọrịa na-efe efe, ihe nyocha antigen na akụkọ nchebe, nke emere n'ịntanetị na offline. inspections, lekwasịrị anya na ịchọta na iwepu iwu na-akwadoghị clues iji bido elu price, na-enyocha na mesoo nke ọma na ngwa ngwa dị ka iwu, na mara ọkwa mbụ itoolu ahụkarị ikpe nke ikenye elu price nke ọrịa metụtara ihe na mgbede nke 16th.
Na Disemba 8, ndị ọrụ mmanye iwu nke Nanxun District Market Supervision Bureau na Huzhou City, Zhejiang Province chọpụtara na ụlọ ọgwụ agbakwunyere ọgwụ ọdịnala na nke ọdịda anyanwụ butere vidiyo na ikpo okwu Tiktok, na-agbasa ozi na ọnụahịa ọgwụ na-efe efe dị ka Lianhua. Qingwen na-achọ ibili nke ukwuu.N'otu ụbọchị ahụ, nyocha nke saịtị ahụ chọpụtara na o biputere ọkwa na mpaghara ọrụ nyocha na ọgwụgwọ, na-ekwu na "n'ihi obere ngwa ahịa na ihe isi ike ịzụrụ, ọnụ ahịa ọgwụ anọ metụtara ọrịa na-efe efe, Lianhua Qingwen, Shuanghuanglian Oral Liquid. , WeiC Yinqiao Mbadamba ụrọ na Banlangen Granules, ga-ebili si December 10 ″.
Onye dị mkpa na-elekọta Nanxun District Market Supervision Bureau kwuru na ụlọ ọgwụ ahụ jiri Tiktok na ikesa ọkwa na mpaghara ọrụ nyocha na ọgwụgwọ iji gbasaa ozi gbasara mmụba ọnụahịa, na-adọta ndị na-azụ ahịa ka ha bịa zụta, na-ebuli atụmanya ọnụahịa, nke a na-enyo enyo. bụrụ omume iwu na-akwadoghị nke ịkwalite ọnụ ahịa.Nanxun District Market Supervision Bureau etinyela nyocha na Disemba 9 ma mee mkpebi maka ntaramahụhụ nchịkwa n'ọdịnihu dị nso.
3. Usoro nke atọ nke ọgwụ mgbochi COVID-19 na Japan bụ 67.4% nke ọnụ ọgụgụ ndị mmadụ
Ihe omuma ohuru nke gọọmentị Japan weputara na 19th gosiri na ọnụ ọgụgụ ndị dechara ọgwụ COVID-19 nke atọ na Japan bụ 84911922, na-aza 67.4% nke ọnụ ọgụgụ ndị bi na ya.
Ihe omuma a gosiputara na onu ogugu ndi mechachara ogwu mbu nke ogwu COVID-19 na Japan bu 81.4% nke onu ogugu obodo;Onu ogugu ndi mezuru ogwu ogwu nke abuo ruru 80.4% nke onu ogugu.A na-akọ na Japan malitere ịgba ọgwụ mgbochi COVID-19 megide ụdị dị iche iche nke Omikjon na Septemba afọ a, na-eche ndị gbara afọ 12 na karịa ndị natara ọgwụ mgbochi ọ dịkarịa ala abụọ.Dabere na data ahụ, 37582513 ndị mmadụ gbara ọgwụ mgbochi COVID-19 megide ụdị dị iche iche nke Omikjon, na-aza 29.8% nke ngụkọta ndị obodo ahụ.
Dị ka ụlọ ọrụ mgbasa ozi mgbasa ozi Japanese na-akọ na 18th, n'ihi mgbasawanye nke ọrịa COVID-19, ọchịchọ maka ahụ ọkụ na ihe mgbu na-eto eto, ụfọdụ ụlọ ọrụ ahụike na ụlọ ahịa ọgwụ na Japan adịghị enwe ahụ ọkụ na ihe mgbu.N'akụkụ a, Ministri Ahụike, Ọrụ na ọdịmma nke Japan meghere windo pụrụ iche maka ụlọ ọgwụ na-anata ndị ọrịa nwere COVID-19 yana ụlọ ahịa ọgwụ na-enye ọgwụ ndenye ọgwụ iji nyere ụlọ ọrụ dị mkpa aka ịzụta ọgwụ n'aka ndị na-ebubata ya nwere nchekwa zuru oke.Na mgbakwunye, Ministry of Health, Labour and Welfare nyekwara ụlọ ọrụ na-ere ahịa ọgwụ ka ha na-ebute obere ụlọ ahịa ọgwụ ụzọ.
Dị ka ọnụ ọgụgụ nke Ministry of Health, Labour na Welfare nke Japan si kwuo, 70921 ọhụrụ enwetara ikpe na Japan na 19th, na ngụkọta nke 27187394 ikpe;Enwere ọnwụ ọhụrụ 180, ọnụ ọgụgụ ndị nwụrụ anwụ karịrị 53499. Enwere ikpe 7949 enwetara ọhụrụ na Tokyo n'otu ụbọchị, na ikpe ọhụrụ n'otu ụbọchị gafere otu oge nke izu gara aga maka ụbọchị 14 n'usoro.
JinDun Medicalnwere ogologo oge nnyocha sayensị imekọ ihe ọnụ na nkà na ụzụ grafting na Chinese mahadum.Site na akụrụngwa ọgwụ bara ụba nke Jiangsu, ọ nwere mmekọrịta azụmahịa ogologo oge na India, Ndịda Ebe Ọwụwa Anyanwụ Eshia, South Korea, Japan na ahịa ndị ọzọ.Ọ na-enyekwa ọrụ ahịa na ịre ahịa na usoro dum site na etiti ruo na API ngwaahịa emechara.Jiri akụrụngwa nke Yangshi Chemical na-achịkọta na kemịkalụ fluorine iji nye ọrụ nhazi kemịkalụ pụrụ iche maka ndị mmekọ.Nye usoro ihe ọhụrụ na ọrụ nyocha adịghị ọcha iji lekwasị ndị ahịa anya.
JinDun Medical na-ekwusi ike na ịmepụta otu na nrọ, na-eme ka ngwaahịa na ùgwù, nlezianya, siri ike, na-apụ apụ ka ọ bụrụ onye mmekọ tụkwasịrị obi na enyi nke ndị ahịa!Otu nkwụsị ngwọta ndị na-enye ihe ngwọta, R & D ahaziri na ọrụ mmepụta ahaziri maka ndị na-ahụ maka ọgwụ na API, ọkachamaraahaziri ọgwụ mmepụta(CMO) na ndị na-enye ọrụ R&D ọgwụ na mmepụta (CDMO).Jindun ga-eso gị mefuo COVID-19.
Oge nzipu: Dec-23-2022